Skip to main content

Table 1 Socio-demographic and clinical data of LGV cases starting from 2011 until end of June 2017

From: Lymphogranuloma venereum is on the rise in Belgium among HIV negative men who have sex with men: surveillance data from 2011 until the end of June 2017

  2011 n(%) 2012 n(%) 2013 n(%) 2014 n(%) 2015 n(%) 2016 n(%) S1 2017 n(%) TOTAL
Number of LGV cases 21 23 45 58 62 88 46 343
Gender 343/343 known
 Male or Trans female 21 (100%) 23 (100%) 45 (100%) 58 (100%) 61 (98%) 88 (100%) 46 (100%) 342 (99,7%)
 Female 0 (0%) 0 (0%) 0 (0%) 0 (0%) 1 (2%) 0 (0%) 0 (0%) 1 (0,3%)
Transmission of all men 241/343 known
 MSM 13 (100%) 13 (100%) 26 (100%) 42 (100%) 52 (98%) 55 (98%) 37 (97%) 238 (99%)
 HETERO 0 (0%) 0 (0%) 0 (0%) 0 (0%) 1 (2%) 1 (2%) 1 (3%) 3 (1%)
Age scale 343/343 known
 20–30 3 (14%) 5(22%) 2 (4%) 10 (17%) 17 (27%) 14 (16%) 6 (13%) 57 (17%)
 31–40 7 (33%) 7 (30%) 17 (38%) 28 (48%) 14 (23%) 27 (31%) 17 (37%) 117 (34%)
 41–50 8 (38%) 8 (35%) 21 (47%) 15 (26%) 17 (27%) 27 (31%) 14 (30%) 110 (32%)
 51–60 2 (10%) 3 (13%) 5 (11%) 4 (7%) 14 (23%) 18 (20%) 8 (17%) 54 (16%)
  > 61 1 (5%) 0 (0%) 0 (0%) 1 (2%) 0 (0%) 2 (2%) 1 (2%) 5 (1%)
Geographical location in Belgium 338/343 known
 Living in Flemish region 17 (81%) 20 (91%) 37 (84%) 36 (63%) 47 (76%) 61 (69%) 36 (81%) 254 (75%)
 Living in French region 2 (10%) 1 (5%) 2 (5%) 3 (5%) 7 (11%) 11 (12%) 3 (7%) 29 (9%)
 Living in the capital region 2 (10%) 1 (5%) 5 (11%) 18 (32%) 8 (13%) 16 (18%) 5 (11%) 55 (16%)
Kind of Sample 337/343 known
 Anorectal 17 (85%) 22 (96%) 37 (86%) 51 (89%) 56 (92%) 84 (95%) 40 (89%) 307 (91%)
 Genital 3 (15%) 1 (4%) 3 (7%) 6 (11%) 2 (3%) 3 (3%) 2 (4%) 20 (6%)
 Urine 0 (0%) 0 (0%) 2 (5%) 0 (0%) 3 (5%) 1 (1%) 1 (2%) 7 (2%)
 Inguinal 0 (0%) 0 (0%) 1 (2%) 0 (0%) 0 (0%) 0 (0%) 1 (2%) 2 (1%)
 Eye fluid 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 1 (2%) 1 (0,3%)
HIV Status 308/343 known
 Positive 18 (100%) 20 (100%) 40 (95%) 45 (88%) 45 (75%) 63 (84%) 30 (71%) 261 (85%)
 Negative 0 (0%) 0 (0%) 2 (5%) 6 (12%) 15 (25%) 12 (16%) 12 (29%) 47 (15%)
Symptoms 232/343 known
 Proctitis 6 (75%) 2 (50%) 19 (63%) 40 (89%) 43 (81%) 41 (76%) 25 (66%) 176 (76%)
 Inguinal lymphadenopathy or ulcer 0 (0%) 1 (25%) 3 (10%) 0 (0%) 3 (6%) 2 (4%) 3 (8%) 12 (5%)
 Other abdominal symptomsa 0 (0%) 0 (0%) 3 (10%) 3 (7%) 3 (6%) 0 (0%) 1 (3%) 10 (4%)
 Genital Ulcer 2 (25%) 0 (0%) 1 (3%) 1 (2%) 0 (0%) 1 (2%) 1 (3%) 6 (3%)
 Urethritis 0 (0%) 0 (0%) 1 (3%) 1 (2%) 0 (0%) 0 (0%) 0 (0%) 2 (1%)
Other symptomsb 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 1 (2%) 2 (5%) 3 (1%)
Asymptomatic 0 (0%) 1 (25%) 3 (10%) 0 (0%) 4 (8%) 9 (17%) 6 (16%) 23 (10%)
Co-infections other than HIV 197/343 known
 None 6 (40%) 0 (0%) 2 (9%) 7 (25%) 17 (40%) 20 (37%) 10 (33%) 62 (31%)
 Only one 6 (40%) 5 (83%) 20 (91%) 21 (75%) 24 (57%) 34 (63%) 15 (50%) 125 (63%)
 Two or more 3 (20%) 1 (17%) 0 (0%) 0 (0%) 1 (2%) 0 (0%) 5 (17%) 10 (5%)
 Gonorrhea 4 (24%) 5 (71%) 11 (41%) 13 (41%) 9 (19%) 17 (28%) 10 (28%) 69 (35%)
 Syphilis 2 (12%) 2 (29%) 9 (33%) 4 (13%) 8 (17%) 9 (15%) 6 (17%) 40 (20%)
 Hepatitis C 2 (12%) 0 (0%) 4 (15%) 6 (19%) 7 (15%) 10 (17%) 0 (0%) 29 (15%)
 Chlamydia A-K 0 (0%) 0 (0%) 0 (0%) 1 (3%) 4 (9%) 0 (0%) 4 (11%) 9 (5%)
 Hepatitis B 2 (12%) 0 (0%) 1 (4%) 1 (3%) 0 (0%) 1 (2%) 2 (6%) 7 (4%)
 Genital herpes 0 (0%) 0 (0%) 0 (0%) 0 (0%) 2 (4%) 0 (0%) 1 (3%) 3 (2%)
 Otherc 1 (6%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 3 (5%) 3 (8%) 7 (4%)
  1. % removing unknowns – deviations from 100% can be due to rounding
  2. S Six-monthly period
  3. aother abdominal symptoms include rectal ulcers or lesions, fistulas, diarrhoea, constipation, peri-anal pain
  4. bother symptoms include conjunctivitis, arthritis or unknown other symptoms
  5. cother co-infections include shigella, campylobacter, varicella zoster, Mycoplasma genitalium